NCT00626717View on ClinicalTrials.gov

Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Keratoconus
Interventions
PROCEDURE

Riboflavin/UVA crosslinking

Removal of epithelium. Riboflavin eye drops. UVA exposure.

PROCEDURE

Sham treatment

Fluorescein eye drops. Exposure with blue light

Trial Locations (1)

79106

University Eye Hospital Freiburg, Freiburg im Breisgau

All Listed Sponsors
collaborator

Peschke Meditrade, GmbH

INDUSTRY

lead

University Hospital Freiburg

OTHER

NCT00626717 - Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus | Biotech Hunter | Biotech Hunter